State Street
ORGS

State Street’s Orgenesis Inc. Common Stock ORGS Stock Holding History

State Street’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,888
Closed -$47.3K – 4354
2024
Q2 		$47.3K Buy
7,888
+1,122
+17% +$5.89K ﹤0.01% 4151
2024
Q1 		$55.6K Sell
6,766
-2,100
-24% -$11.2K ﹤0.01% 4138
2023
Q4 		$44.4K Hold
8,866
– – ﹤0.01% 4216
2023
Q3 		$53.9K Hold
8,866
– – ﹤0.01% 4270
2023
Q2 		$123K Hold
8,866
– – ﹤0.01% 4169
2023
Q1 		$105K Hold
8,866
– – ﹤0.01% 4311
2022
Q4 		$173K Hold
8,866
– – ﹤0.01% 4162
2022
Q3 		$126K Hold
8,866
– – ﹤0.01% 4367
2022
Q2 		$215K Hold
8,866
– – ﹤0.01% 4163
2022
Q1 		$308K Buy
8,866
+616
+7% +$18.7K ﹤0.01% 4230
2021
Q4 		$238K Hold
8,250
– – ﹤0.01% 4273
2021
Q3 		$408K Hold
8,250
– – ﹤0.01% 4056
2021
Q2 		$418K Sell
8,250
-20,294
-71% -$1.02M ﹤0.01% 3926
2021
Q1 		$1.64M Buy
28,544
+1,461
+5% +$95.2K ﹤0.01% 3509
2020
Q4 		$1.22M Buy
27,083
+3,575
+15% +$172K ﹤0.01% 3523
2020
Q3 		$1.19M Sell
23,508
-412
-2% -$22.3K ﹤0.01% 3393
2020
Q2 		$1.45M Buy
+23,920
New +$1.45M ﹤0.01% 3304

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State Street's ORGS Position: Q3 2024 in Review

State Street sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2024, closing a stake of 7,888 shares — an estimated $47.3K sold.

State Street first reported a position in ORGS in Q2 2020 and held it in 17 quarters. The position peaked at $1.64M in Q1 2021. 11 funds tracked by Wall St. Rank hold ORGS as of Q3 2024.

  • State Street reported no remaining Orgenesis Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • State Street sold 7,888 Orgenesis Inc. Common Stock shares in Q3 2024, an estimated $47.3K.
  • State Street first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 17 quarters.
  • State Street's Orgenesis Inc. Common Stock position peaked at $1.64M in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2024.

Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.